Kutatási jelek – Signal Engine

• A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug — Adenoid cystic carcinoma
• Integrated genomic and molecular characterization of cervical cancer — Cervical cancer
• Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments? — Cholangiocarcinoma
• Milestones in Chronic Lymphocytic Leukemia — Chronic lymphocytic leukemia
• UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST) — Gastrointestinal stromal tumor
• Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach — Gastrointestinal stromal tumor
• Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study — Diffuse large B-cell lymphoma
• Treatment of metastatic uveal melanoma with adoptive transfer of tumor infiltrating lymphocytes: a single‑center phase 2 study — Melanoma
• Treatment and Survival of Childhood Neuroblastoma: Evidence from a Population-Based Study in the United States — Neuroblastoma
• Colorectal Cancer Incidence Patterns in the United States, 1974-2013 — Colorectal cancer
• 20‑Year Risks of Breast‑Cancer Recurrence after Stopping Endocrine Therapy at 5 Years — Breast cancer
• Screen‑and‑Treat Strategy for Helicobacter pylori Infection Reduces Gastric Cancer Mortality — Gastric cancer
• Epidemiology and Outcome of Glioblastoma — Glioblastoma
• Bladder cancer — Bladder cancer
• Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment — Glioblastoma
• Renal cell carcinoma — Renal cell carcinoma
• CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data — Breast cancer
• DCEG Studies of Cancer of the Endometrium and Uterus — Endometrial cancer
• Research and clinical trials for thyroid cancer — Thyroid cancer
• The Early Breast Cancer Trialists' Collaborative Group (EBCTCG) — Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) — Breast cancer